NFKB1 and ovarian neoplasm: It can decrease the pro-inflammatory cytokines such as IL-6, IL-1, TNF-α and NF-κB and promotes a pro-apoptotic and anti-angiogenic effect in tumours such as ovarian tumours [37, 42–44].